Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio (2016 - 2026)

Amphastar Pharmaceuticals has reported Debt Ratio over the past 13 years, most recently at 0.37 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 1.81% year-over-year to 0.37; the TTM value through Dec 2025 reached 0.37, down 1.81%, while the annual FY2025 figure was 0.37, 1.81% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.37 at Amphastar Pharmaceuticals, up from 0.37 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.41 in Q3 2023 and troughed at 0.06 in Q2 2021.
  • A 5-year average of 0.25 and a median of 0.36 in 2025 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: dropped 17.52% in 2021 and later surged 296.95% in 2023.
  • Year by year, Debt Ratio stood at 0.11 in 2021, then dropped by 10.78% to 0.1 in 2022, then surged by 281.32% to 0.39 in 2023, then fell by 2.17% to 0.38 in 2024, then fell by 1.81% to 0.37 in 2025.
  • Business Quant data shows Debt Ratio for AMPH at 0.37 in Q4 2025, 0.37 in Q3 2025, and 0.38 in Q2 2025.